Compare Stocks

Back to Screener

Select Stocks to Compare

Add or remove up to 5 stocks to perform stock analysis, comparing market price, stock performance, and financial statements for informed decisions.

Stock Comparison Charts

Metric
Aarti Drugs Limited

Healthcare

Drug Manufacturers - Specialty & Generic
Ajanta Pharma Limited

Healthcare

Drug Manufacturers - Specialty & Generic
Anuh Pharma Limited

Healthcare

Drug Manufacturers - Specialty & Generic
Lupin Limited

Healthcare

Drug Manufacturers - Specialty & Generic
Stock Details
Current Price 434.2 2565.0 205.33 1934.5
Previous Close 440.65 2588.2 206.54 1948.0
Open 441.6 2559.6 204.0 1925.1
Day Low 432.3 2540.0 203.45 1921.4
Day High 441.6 2571.9 207.36 1948.1
Market Cap 39669903360.0 320399278080.0 10317401088.0 883476463616.0
P/E Ratio 23.69 34.9 21.71 26.98
Forward P/E 15.34 25.84 N/A 23.66
Earnings Per Share 18.33 73.5 9.46 71.69
Dividend Yield (%) 0.23 2.09 0.73 0.41
Beta 0.41 0.24 0.45 0.31
EBITDA 2870599936.0 12522399744.0 609086976.0 54966898688.0
Book Value 149.84 301.59 65.17 377.02
Debt to Equity 44.92 1.34 3.34 31.5
ROCE (%) N/A N/A N/A N/A
ROE (%) N/A N/A N/A N/A
Face Value N/A N/A N/A N/A
Price to Book 2.9 8.51 3.15 5.13
Performance
1Y Return (%) -1453.65 1111.97 -731.88 2433.38
About Company
Founded Year N/A N/A N/A N/A
Employees N/A 9628 N/A N/A
Website Live Website of AARTIDRUGS Live Website of AJANTPHARM Live Website of ANUHPHR Live Website of LUPIN

Company Overviews & Financial Position

Review detailed company profiles, including business summaries and key insights into their balance sheet and company financial position to aid in buying or selling decisions.

Aarti Drugs Limited

Aarti Drugs Limited, through its subsidiaries, manufactures and markets active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and formulations in India and internationally. The company offers aceclofenac, celecoxib, diclofenac sodium, diclodenac potassium, diclofenac diethylamine, diclofenac resinate, diclofenac epolamine, nimesulide, ciprofloxacin HCL, enrofloxacin base, gatifloxacin sesquihydrate, levofloxacin base, moxifloxacin, norfloxacin, ofloxacin, metronidazole benzoate, ornidazole, secnidazole, tinidazole, clopidogrel bisulphate, ticlopidine HCL, metformin HCL, pioglitazone HCL, teneligliptin, vildagliptin, fluconazole, ketoconazole, tolnaftate, zolpidem tartrate, niacin, raloxifene HCL, and acamprosate. It also provides benzene sulphonyl chloride, benzene sulphonic acid, benzene sulphonic acid methyl ester, sodium benzene sulfinate, para toluene sulphonyl chloride, methyl para toluenesulfonate, sodium para toluenesulfinate, para chlorobenzenesulfonyl chloride, formamide, calcium fluoride, potasium formate, benzenesulfonamide, ethyl p- toluenesulfonate, N,N',N'-tris-(4-toluene sulfonyl)-diethylenetriamine, ortho para toluene sulfonamides, ortho para toluene sulfonamides acid methyl ester, para chlorobenznesulfonamide, para toluenesulfonyl hydrazide, para toluenesulfonamide, and sodium benzenesulfonate. In addition, it offers pharma intermediate products, which includes Celecoxib, Ciprofloxacin, Clopidogrel, Diclofenac, Ketoconazole, Nimesulide, Raloxifene, Tinidazole, and Zolpidem. Further, the company develops drugs for the antioxidant, antifungal, cardiovascular, and antidiabetic therapeutic areas. The company was incorporated in 1984 and is headquartered in Mumbai, India.

Ajanta Pharma Limited

Ajanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company that develops, manufactures, and markets specialty pharmaceutical finished dosages. The company offers chronic and acute therapies; branded generic products; and a range of dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids. It also serves various therapeutic areas comprising cardiology, dermatology, ophthalmology, and pain management. The company operates in India, Africa, Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.

Anuh Pharma Limited

Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-malarial, anti-bacterial, anti-hypertension, expectorant, quinolones, and intermediates. The company also provides corticosteroids, such as anti-inflammatory, immunosuppressant, anti-pruritic, anti-mitotic, and anti-histamines. It also exports its products. The company was incorporated in 1960 and is headquartered in Mumbai, India.

Lupin Limited

Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India and internationally. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutical ingredients (APIs). The company offers formulations for use in the therapeutic areas of anti-tuberculosis, diabetes management, cardiovascular, chronic obstructive pulmonary diseases, asthma, gynecology and women's health, central nervous system, oncology, immunology, genomics, metabolic disorders, dermatology, urology, pediatrics, gastrointestinal, anti-infective, and nonsteroidal anti-inflammatory drug therapies, as well as engages in the bio clinical research activities. It operates through network consists of labs, LupiMitra collection centers, and pick-up points. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.